Aptose Biosciences Stock Net Income
| APTODelisted Stock | USD 2.01 0.91 82.73% |
By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess Aptose Biosciences' long-term financial health and intrinsic value.
Aptose |
Aptose Biosciences Company Net Income Analysis
Aptose Biosciences' Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current Aptose Biosciences Net Income | (25.43 M) |
Most of Aptose Biosciences' fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Aptose Biosciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
CompetitionBased on the recorded statements, Aptose Biosciences reported net income of (25.43 Million). This is 107.45% lower than that of the Biotechnology sector and 136.3% lower than that of the Health Care industry. The net income for all United States stocks is 104.45% higher than that of the company.
Aptose Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Aptose Biosciences' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Aptose Biosciences could also be used in its relative valuation, which is a method of valuing Aptose Biosciences by comparing valuation metrics of similar companies.Aptose Biosciences is currently under evaluation in net income category among its peers.
Aptose Fundamentals
| Return On Equity | -6.94 | |||
| Return On Asset | -1.42 | |||
| Current Valuation | 9.69 M | |||
| Shares Outstanding | 2.55 M | |||
| Shares Owned By Insiders | 24.80 % | |||
| Shares Owned By Institutions | 11.51 % | |||
| Number Of Shares Shorted | 53.15 K | |||
| Price To Earning | (1.80) X | |||
| Price To Book | 67.84 X | |||
| EBITDA | (36.15 M) | |||
| Net Income | (25.43 M) | |||
| Cash And Equivalents | 62.41 M | |||
| Cash Per Share | 0.68 X | |||
| Total Debt | 621 K | |||
| Debt To Equity | 0.01 % | |||
| Current Ratio | 6.89 X | |||
| Book Value Per Share | (14.04) X | |||
| Cash Flow From Operations | (35.98 M) | |||
| Short Ratio | 0.14 X | |||
| Earnings Per Share | (36.38) X | |||
| Target Price | 12.5 | |||
| Number Of Employees | 35 | |||
| Beta | 1.13 | |||
| Market Capitalization | 4.36 M | |||
| Total Asset | 10.13 M | |||
| Retained Earnings | (540.97 M) | |||
| Working Capital | 5.07 M | |||
| Current Asset | 14.98 M | |||
| Current Liabilities | 1.7 M | |||
| Net Asset | 10.13 M |
About Aptose Biosciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Aptose Biosciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Aptose Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Aptose Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Other Consideration for investing in Aptose Stock
If you are still planning to invest in Aptose Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aptose Biosciences' history and understand the potential risks before investing.
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Stocks Directory Find actively traded stocks across global markets | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |